Validating CGM for GDM (NCT06858787)
The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Who can join: Review the eligibility criteria below.
Location: Mount Sinai West — New York, New York
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Mount Sinai West — New York, New York
- Icahn School of Medicine at Mount Sinai — New York, New York
- Mount Sinai South Nassau — Oceanside, New York
📞 Contact the Study Coordinator
Phone: (212) 241-3888
Email: nicola.tavella@mssm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gestational Diabetes Mellitus (GDM)
- A Probiotic Based Intervention in Pregnancies Complicated by GDM — Kingston, Ontario
- The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial (EAGER Pilot Trial) — Ottawa, Ontario
- Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes — Sacramento, California
- Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes — Norfolk, Virginia
- The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy — Iowa City, Iowa
Explore by condition: All Gestational Diabetes Mellitus (GDM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.